China Money Network
Login
Join

Chinese Biomedical CRO Biocytogen Raises $77M In Series D Round

  • August 8, 2019 — 12:40 CST

This Data Is Locked!

This area is available only to Subscribers.

Biocytogen, a biomedical contract research organization (CRO) specialized in gene-targeted animal models and services, announced on Thursday that it has raised RMB543 million (US$77.11 million)... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: